EIF2A Produits
(Eukaryotic Translation Initiation Factor 2A, 65kDa (EIF2A))
Catégories
EIF2A is a 65-kD protein that catalyzes the formation of puromycin-sensitive 80S preinitiation complexes (Zoll et al., 2002 [PubMed 12133843]).[supplied by OMIM, Mar 2008].
antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.
Catégories EIF2A en vedette
EIF2A Anticorps
High quality antibodies with extensive validation data.
EIF2A Kits ELISA
Reliable ELISA kits for a wide range of species.
EIF2A Protéines
Proteins for various applications incl. WB, ELISA, IF etc.
EIF2A recommandé Anticorps
Produit
Reactivity
Application
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human, Monkey, Mouse, Rat
Application
WB, IHC, ELISA, FACS
Validations
- (2)
- (7)
N° du produit
ABIN1724933
Quantité
0.1 mg
Fiche technique
Fiche technique
Reactivity
Human
Application
WB, IHC, ELISA, FACS, ICC
Validations
- (2)
- (7)
N° du produit
ABIN1724939
Quantité
0.1 mg
Fiche technique
Fiche technique
Reactivity
Human
Application
WB, IHC
Validations
- (5)
N° du produit
ABIN7267035
Quantité
100 μL
Fiche technique
Fiche technique
EIF2A recommandé Kits ELISA
Produit
Reactivity
Analytical Method
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human
Analytical Method
Quantitative Sandwich ELISA
Validations
- (1)
N° du produit
ABIN4993426
Quantité
96 tests
Fiche technique
Fiche technique
Reactivity
Human, Mouse, Rat
Analytical Method
Qualitative Cell ELISA
Validations
N° du produit
ABIN1380564
Quantité
2 x 96 tests
Fiche technique
Fiche technique
Reactivity
Human
Analytical Method
Quantitative Competition ELISA
Validations
N° du produit
ABIN5661958
Quantité
96 tests
Fiche technique
Fiche technique
EIF2A recommandé Protéines
Produit
Reactivity
Source
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human
Source
Escherichia coli (E. coli)
Validations
- (1)
N° du produit
ABIN7122840
Quantité
50 μg
Fiche technique
Fiche technique
Reactivity
Human
Source
Escherichia coli (E. coli)
Validations
- (1)
N° du produit
ABIN7122841
Quantité
50 μg
Fiche technique
Fiche technique
Reactivity
Human
Source
Wheat germ
Validations
- (1)
N° du produit
ABIN1799436
Quantité
10 μg
Fiche technique
Fiche technique
Dernières publications sur nos produits EIF2A
: "Therapeutic Role of Protein Tyrosine Phosphatase 1B in Parkinson's Disease via Antineuroinflammation and Neuroprotection In Vitro and In Vivo." dans: Parkinson's disease, Vol. 2020, pp. 8814236, (2020) (PubMed).: "miR-211 Plays a Critical Role in Cnidium officinale Makino Extract-Induced, ROS/ER Stress-Mediated Apoptosis in U937 and U266 Cells." dans: International journal of molecular sciences, Vol. 19, Issue 3, (2018) (PubMed).
: "Arrestins contribute to amyloid beta-induced cell death via modulation of autophagy and the α7nAch receptor in SH-SY5Y cells." dans: Scientific reports, Vol. 7, Issue 1, pp. 3446, (2017) (PubMed).
: "A non-canonical pathway regulates ER stress signaling and blocks ER stress-induced apoptosis and heart failure." dans: Nature communications, Vol. 8, Issue 1, pp. 133, (2017) (PubMed).
: "Luteolin and Apigenin Attenuate 4-Hydroxy-2-Nonenal-Mediated Cell Death through Modulation of UPR, Nrf2-ARE and MAPK Pathways in PC12 Cells." dans: PLoS ONE, Vol. 10, Issue 6, pp. e0130599, (2016) (PubMed).
: "Sustained endoplasmic reticulum stress inhibits hepatocyte proliferation via downregulation of c-Met expression." dans: Molecular and cellular biochemistry, Vol. 389, Issue 1-2, pp. 151-8, (2014) (PubMed).
: "Distinctive subcellular inhibition of cytokine-induced SRC by salubrinal and fluid flow." dans: PLoS ONE, Vol. 9, Issue 8, pp. e105699, (2014) (PubMed).
: "Protein kinase R is responsible for the phosphorylation of eIF2alpha in rotavirus infection." dans: Journal of virology, Vol. 84, Issue 20, pp. 10457-66, (2010) (PubMed).
: "Inhibition of Golgi apparatus glycosylation causes endoplasmic reticulum stress and decreased protein synthesis." dans: The Journal of biological chemistry, Vol. 285, Issue 32, pp. 24600-8, (2010) (PubMed).
: "Investigation of the eIF2alpha phosphorylation mechanism in response to proteasome inhibition in melanoma and breast cancer cells." dans: Molekuliarnaia biologiia, Vol. 44, Issue 5, pp. 859-66, (2010) (PubMed).
Synonymes et noms alternatifs relatifs à EIF2A
eukaryotic translation initiation factor 2 alpha subunit (EIF2 ALPHA), eukaryotic translation initiation factor 2A (EIF2A), eukaryotic translation initiation factor 2A (Eif2a), eukaryotic translation initiation factor 2A (eif2a), eukaryotic translation initiation factor 2A (eIF2a), eukaryotic translation initiation factor 2A, 65kDa (Eif2a), eukaryotic translation initiation factor 2A S homeolog (eif2a.S), eukaryotic translation initiation factor (eif2A), eukaryotic translation initiation factor (EIF2A), eukaryotic translation Initiation Factor 2alpha (eIF-2alpha), ATEIF2-A2, CG9946, D030048D22, D3Ertd194e, DDBDRAFT_0185936, DDBDRAFT_0234177, DDB_0185936, DDB_0234177, deIF2alpha, Dmel\\CG9946, eIF-2, eIF-2 a, eIF-2 alpha, EIF-2A, eiF-2alpha, eIF2 alpha, EIF2-A2, eIF2-alpha, Eif2a, eif2a, EIF2A, eIF2a, eif2alpha, Eif2alpha, eIF2alpha, elF2alpha, eukaryotic translation initiation factor 2 alpha subunit, IF2A_DROME, im:7145971, l(1)14Cf, l(1)19-153, M(1)8e3-10, M(1)14C, M(1)19-153, MST089, MSTP004, MSTP089, zgc:110460Protein level used designations for EIF2A
- 65 kDa eukaryotic translation initiation factor 2A
- eukaryotic translation initiation factor 2A
- eIF-2A
- Eukaryotic translation initiation factor 2A
- eukaryotic translation initiation factor 2A, 65kDa
- eukaryotic translation initiation factor
- eukaryotic translation initiation factor 2A-like
- CG9946-PA
- eIF-2alpha-PA
- eukaryotic initiation factor 2alpha
- eukaryotic translation initiation factor 2
- eukaryotic translation initiation factor 2alpha
- minute (1) 14C
Vous êtes ici:
